Journal
THERANOSTICS
Volume 5, Issue 8, Pages 796-804Publisher
IVYSPRING INT PUBL
DOI: 10.7150/thno.11220
Keywords
lymphoma; microfluidics; point-of-care; cerebrospinal fluid; drug testing
Categories
Funding
- Harvard Biophysics Graduate Program under NIH training grant [T32008313]
- NSF Graduate Research Fellowship [DGE0946799, DGE1144152]
Ask authors/readers for more resources
Molecular profiling of central nervous system lymphomas in cerebrospinal fluid (CSF) samples can be challenging due to the paucicellular and limited nature of the samples. Presented herein is a microfluidic platform for complete CSF lymphoid cell analysis, including single cell capture in sub-nanoliter traps, and molecular and chemotherapeutic response profiling via on-chip imaging, all in less than one hour. The system can detect scant lymphoma cells and quantitate their kappa/lambda immunoglobulin light chain restriction patterns. The approach can be further customized for measurement of additional biomarkers, such as those for differential diagnosis of lymphoma subtypes or for prognosis, as well as for imaging exposure to experimental drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available